Overview
A well-prepared submission package is essential for a smooth CTIL and CTX approval process Malaysia. Incomplete documentation, missing compliance records, or incorrect submission details may lead to NPRA queries, screening delays, or rejection during evaluation.
This checklist provides a practical overview of the major documentation, compliance, and submission requirements sponsors should prepare before initiating clinical trials involving unregistered products in Malaysia.
Aligned with current NPRA clinical trial approval Malaysia requirements and the Malaysian Guideline for Application of Clinical Trial Import Licence and Clinical Trial Exemption, this checklist can help organizations streamline approvals and reduce Regulatory delays.
Who Should Use This Checklist?
- Pharmaceutical and biotechnology companies planning clinical trials in Malaysia
- Sponsors applying for CTIL or CTX approvals
- Regulatory affairs professionals managing clinical trial submissions
- CROs supporting Regulatory operations and trial management
- Local agents representing foreign sponsors
- Clinical investigators and Phase I trial units
Fill the form below to download the Checklist